ÂÜÀòÂÒÂ×

Ivan Gergel is a seasoned executive in the healthcare and pharmaceutical sectors, currently serving as Chairman of the Board of Directors at Corsair Pharma since September 2023. Gergel has held notable positions such as Director on the Board of Directors for various companies including Theranica Bio-Electronics Ltd., Butterfly Medical, and Neuraptive Therapeutics. Additionally, Gergel has been managing partner and Chief Medical Officer at New Rhein Healthcare Investors since March 2018. Gergel's extensive experience includes leadership roles in previous companies like Travecta Therapeutics, Neurotrope Inc., Realm Therapeutics, and Corium. An accomplished academic, Gergel holds an MD from the University of London, an MRCPsych from the Royal College of Psychiatrists, and an MBA from The Wharton School.